放射学与病理学特征对非特发性肺纤维化间质性肺病患者进展性肺纤维化发生的预后影响
回顾性纳入2004年1月至2020年12月间经外科肺活检诊断的非特发性肺纤维化间质性肺病患者75例,由3名胸部放射科医师独立评估术前及随访CT特征与纤维化范围,2名病理科医师评估组织病理学特征。多变量分析显示CT牵拉性支气管扩张与进展性肺纤维化显著相关(校正HR 6.40,P=0.003),放射学进展(校正HR 18.44,P<0.001)、症状进展(校正HR 4.19,P=0.011)及年龄(每增加1岁校正HR 1.12,P<0.001)与死亡显著相关。作者认为细致的放射学评估和症状监测可能有助于预测非特发性肺纤维化间质性肺病患者的疾病进展和结局。
要点
- CT牵拉性支气管扩张是非特发性肺纤维化间质性肺病患者进展性肺纤维化的显著预测因素(校正HR 6.40,P=0.003)。
- 放射学进展(校正HR 18.44,P<0.001)和症状进展(校正HR 4.19,P=0.011)与死亡显著相关。
- 年龄每增加1岁与死亡风险相关(校正HR 1.12,P<0.001)。
核心结论
- CT牵拉性支气管扩张是非特发性肺纤维化间质性肺病患者进展性肺纤维化的显著预测因素,而放射学进展、症状进展和年龄较大与更差的生存相关。
研究设计与样本
- 回顾性纳入2004年1月至2020年12月间经外科肺活检诊断的非特发性肺纤维化间质性肺病患者75例,3名胸部放射科医师独立评估术前及随访CT特征与纤维化范围,2名病理科医师评估组织病理学特征,采用Kaplan-Meier法估计进展性肺纤维化时间和总生存,分别用标准Cox回归和时间依赖Cox模型分析CT及病理特征与进展性肺纤维化和全因死亡的关联。
诊断标准与关键数值
- CT牵拉性支气管扩张与进展性肺纤维化显著相关(校正HR 6.40,P=0.003)。
- 体重指数每增加1 kg/m²与进展性肺纤维化相关(校正HR 0.82,P=0.002)。
- 放射学进展与死亡显著相关(校正HR 18.44,P<0.001)。
- 症状进展与死亡显著相关(校正HR 4.19,P=0.011)。
- 年龄每增加1岁与死亡显著相关(校正HR 1.12,P<0.001)。
临床应用与阅片要点
- 作者认为,细致的放射学评估和症状监测可能有助于预测非特发性肺纤维化间质性肺病患者的疾病进展和结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the prognostic impact of radiologic and pathologic features in patients with interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis (IPF), and to identify the factors associated with the development of progressive pulmonary fibrosis (PPF) and survival.
MATERIALS AND METHODS: This study retrospectively enrolled 75 patients diagnosed with ILD other than IPF who underwent surgical lung biopsy between January 2004 and December 2020. Three chest radiologists independently reviewed the CT features and extent of fibrosis on preoperative and follow-up CT scans. Two pathologists reviewed the histopathological features, including the presence of interstitial pneumonia. The time to PPF and overall survival were estimated using the Kaplan-Meier method. The associations of CT and pathological features with PPF and all-cause mortality were examined using standard Cox regression and time-dependent Cox models, respectively.
RESULTS: A total of 75 non-IPF ILD patients (mean age ± standard deviations 56.4 ± 13.2 years; range, 40-88 years) were enrolled. The median follow-up duration was 75.3 months (range, 7.8-189.8 months). Traction bronchiectasis on CT (adjusted hazard ratio [HR], 6.40; P = 0.003) and body mass index (adjusted HR per 1-kg/m² increase, 0.82; P = 0.002) were found to be significantly associated with PPF in multivariable analysis. Radiological progression (adjusted HR, 18.44; P < 0.001), symptomatic progression (adjusted HR, 4.19; P = 0.011), and age (adjusted HR for 1-year increase, 1.12; P < 0.001) were significantly associated with death.
CONCLUSION: Traction bronchiectasis on CT was a significant predictor of PPF, while radiologic and symptomatic progression and older age were associated with poorer survival in patients with ILD other than IPF. These findings indicate that careful radiological evaluation and symptom monitoring may help to predict disease progression and outcomes in patients with non-IPF ILD.
引用
- Cho HR, Chung MJ, Choi H, et al. Prognostic Impact of Radiologic and Pathologic Features on the Development of Progressive Pulmonary Fibrosis in Patients With Interstitial Lung Disease Other Than Idiopathic Pulmonary Fibrosis. Korean J Radiol. 2026. PMID: 41494677. doi:10.3348/kjr.2025.0977
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。